JPM Presentation 1.9.23 Final Version V3Ascendis.pdf

1、Ascendis Pharma A/S41st Annual J.P.Morgan Healthcare ConferenceJanuary 9,2023For investor communication only.Not for use in product promotion.Not for further distribution.Cautionary Note on Forward-Looking StatementsThis presentation contains forward-looking statements.All statements other than stat

2、ements of historical facts contained in this presentation,such as statements regarding our prospective product candidates;clinical trial results;the expected timing of future clinical trial results;the scope,progress,results and costs of developing our product candidates or any other future product

3、candidates;timing and likelihood of success;plans and objectives of management for future operations;and future results of current and anticipated products and product candidates are forward-looking statements.These forward-looking statements are based on our current expectations and beliefs,as well

4、 as assumptions concerning future events.These statements involve known and unknown risks,uncertainties and other factors that could cause our actual results to differ materially from the results discussed in the forward-looking statements.These risks,uncertainties and other factors are more fully d

5、escribed in our reports filed with or submitted to the Securities and Exchange Commission,including,without limitation,our most recent Annual Report on Form 20-F filed with the SEC on March 2,2022 particularly in the sections titled“Risk Factors”and“Operating and Financial Review and Prospects.”In l

6、ight of the significant uncertainties in our forward-looking statements,you should not place undue reliance on these statements or regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified timeframe,or at all.Any